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mixed, most likely associated with different levels 
of adherence.3 It also appears that women need 
to take daily oral PrEP for a longer period of time 
than men before they acquire protective levels 
of the drug in their body.2,5-7 For young women, 
emerging data show that when women know that 
PrEP is effective, they use it more consistently.8 
Given their increased vulnerability to HIV infec-
tion, PrEP could have a significant impact on HIV 
acquisition among AGYW, if they are able to effec-
tively access and use PrEP. Thus, we need to fill 
existing gaps in knowledge about how different 
stakeholders will perceive PrEP, how AGYW will 
use it in real-world settings, and how to design 
and implement effective service delivery models.
Currently there is great interest and momentum 
in bringing PrEP to populations at substantial risk 
of HIV, including AGYW. Decreasing infections 
among young people is a key aspect of the global 
ALL IN intitiave to accelerate the fight against 
AIDS for adolescents. Further, the World Health 
Organization (WHO)4 recommends the availability 
and use of oral PrEP to mitigate HIV acquisition. 
The DREAMS (Determined, Resilient, Empow-
Introduction
Keeping adolescent girls and 
young women HIV- and AIDS-free 
is critical for their well-being and 
health, the health of their families 
and communities, and their 
countries’ future.
—PEPFAR
Adolescent girls and young women (AGYW), ages 
15–24 years, account for 75 percent of young 
people in sub-Saharan Africa who are living with 
HIV.1 As many as 7,000 new infections a week 
are occurring among the most vulnerable AGYW 
in Eastern and Southern Africa; AIDS is the 
leading cause of death for adolescent girls ages 
10–19 in Africa.1 In sub-Saharan Africa, women 
acquire HIV five to seven years earlier than men, 
and young women are at an increased risk of HIV 
acquisition compared to young men.1 To date, 
prevention efforts have not had the maximum 
impact on AGYW’s risk of acquiring HIV.2 The Joint 
United Nations Programme on HIV/AIDS (UN-
AIDS), highlights gender-based violence, limited 
access to health services, limited education, and 
policies or systems that exclude young women as 
the key contributors to AGYW’s increased vulner-
ability to HIV.1 The introduction of pre-exposure 
prophylaxis (PrEP) within the context of a com-
prehensive HIV prevention package, would make 
a new HIV prevention option available for AGYW, 
offering them an opportunity for more control of 
their sexual health.
Oral PrEP, the use of antiretroviral (ARV) medi-
cations by HIV-negative persons to prevent the 
acquisition of HIV, is a new biomedical interven-
tion that has the potential to substantially reduce 
HIV acquisition among those most vulnerable 
to HIV. Recent evidence indicates that PrEP is 
efficacious in different populations at high risk of 
HIV acquisition—in studies with high adherence, 
HIV infection risk was reduced by 70 percent.3 
Trial results have shown that oral PrEP in men 
who have sex with men significantly reduces the 
risk of HIV acquisition by as much as 92 percent 
when taken as prescribed.4 Results on the effi-
cacy of PrEP for women, aged 18 and older, are 
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ered AIDS-free, Mentored, and Safe) initiative—a 
partnership between the U.S. President’s Emer-
gency Plan for AIDS Relief (PEPFAR), the Bill & 
Melinda Gates Foundation, and Girl Effect, plus 
Johnson & Johnson, Gilead Sciences, and ViiV 
Healthcare9—aims to significantly reduce new 
HIV infections among AGYW in 10 countries in 
sub-Saharan Africa by providing a core package 
of interventions to AGYW residing in areas with 
high HIV prevalence. The provision of PrEP is cur-
rently part of the prevention package for some of 
the DREAMS countries, and is being considered 
by several others. Under the DREAMS mandate 
and other global efforts, new programmatic 
strategies for introducing this innovative product 
in real-world settings are being developed and 
implemented. There is an urgent need for imple-
mentation science to complement biomedical, 
clinical, and product marketing research in order 
to appropriately introduce PrEP to AGYW. 
The equitable and ethical introduction of this 
new biomedical intervention has to take into 
account the particular vulnerabilities that AGYW 
may face; these include, but are not limited to, 
legal and policy constraints affecting access 
and ability to consent to sexual and reproductive 
health services, stigma around AGYW sexuality, 
power dynamics between AGYW and parents and 
partners, experiences of violence and coercion, 
and individual capacity to assess HIV risk.10 
Further, the past introduction of a number of 
health technologies for women (e.g., human 
papillomavirus vaccine, emergency contracep-
tion) have highlighted women’s concerns around 
how a product works, whether it has the potential 
to cause harm, whether it will jeopardize fertility, 
and whether it will influence relationships.11 As 
countries consider and plan to introduce and 
expand PrEP implementation under DREAMS 
and other initiatives, there is a need to carefully 
examine the individual behavioral factors as well 
as the structural and sociocultural factors that 
may influence PrEP acceptability, uptake, and 
adherence among AGYW. Countries also will need 
to develop a vision for how PrEP for AGYW fits into 
the overall HIV prevention landscape and how to 
address challenges associated with its introduc-
tion,11 such as determining the: 
• Most appropriate sub-populations of AGYW 
for using PrEP, given the nature of the HIV 
epidemic within the country.12 
• Feasibility of introducing PrEP to AGYW in 
a safe and ethical way that supports their 
human rights. 
• Ability of health services to reach the most 
vulnerable AGYW. 
• Influence of service providers, partners, 
families, and communities on AGYW’s 
acceptance of PREP. 
• Willingness of AGYW to utilize and adhere to 
PrEP. 
• Policy and service delivery issues that arise in 
the early stages of new product introduction. 
• Best ways to introduce PrEP to AGYW into 
existing health care systems.
PURPOSE OF THE DOCUMENT
This document was developed by the Population 
Council, with support from the Bill & Melinda 
Gates Foundation, to provide DREAMS country 
teams with practical guidance on building evi-
dence to guide PrEP introduction for AGYW. 
Countries will need to develop a 
vision for how PrEP for AGYW fits 
into their overall HIV prevention 
landscape and how to address 
challenges associated with its 
introduction. 
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The primary audiences for this document are 
health policy makers and program planners 
who will be making decisions about how PrEP is 
introduced to AGYW and the researchers who will 
assess AGYW’s specific needs and experiences. 
Our aim is to complement emerging global 
guidance on PrEP1 and on-going work regarding 
delivery platforms, marketing, and policy and 
regulatory frameworks for PrEP introduction more 
generally. We focus on examining the factors 
that influence informed choice, demand, and 
use of PREP by young women and that influence 
client-provider interactions. Further, we hope this 
document can serve as a useful guide to gather 
data on user, community, and provider perspec-
tives as countries move from introduction to 
broad-based implementation of PrEP.
This practical guidance document is informed by 
the Population Council’s work on HIV prevention 
product introduction for women11,12 and builds 
on our commitment to understanding whether, 
when, how, and under what circumstances ARV-
based prevention would be beneficial for AGYW. 
ETHICAL CONSIDERATIONS
Depending upon the types of data to be 
collected, and for what purpose (for program de-
velopment versus research publication), the data 
collection proposed in this document may need 
to undergo an ethical review, may be exempt from 
an ethical review, or may be considered to not 
be research (and therefore not require an ethical 
review). As guidelines for ethical reviews vary by 
setting and organization, it is recommened that 
you check with your local ethical/institutional 
review board to determine the best way forward. 
1The WHO is currently developing comprehensive global im-
plementation guidelines for PrEP. 
Regardless of whether the data collection pro-
posed in this document must undergo an ethical 
review, it is the responsibility of the research 
team to fulfill several obligations and ensure 
safeguards in planning and conducting the 
research, as well as reporting research findings. 
Specifically, ethical standards need to be met for 
maintaining the dignity and welfare of all partici-
pants; protecting them from harm, unnecessary 
risk, or mental and physical discomfort; and 
ensuring that respondents are not being unduly 
influenced or induced into participation in the re-
search. Further, ethical guidelines pertaining  to 
the accurate and appropriate use of data should 
be maintained by researchers and others using 
the data. These issues are particularly important 
to consider when conducting research with mi-
nors (those below the age of legal consent) and 
marginalized populations. 
Several available resources provide guidance 
on research with minors and should be con-
sulted during the design and development of 
this research. Some examples include http://
childethics.com and http://www.popcouncil.org/
uploads/pdfs/horizons/childrenethics.pdf.
Before data collection, all participants should be 
given information on PrEP attributes. UNAIDS’ 
“Oral pre-exposure prophylaxis—Questions and 
answers” is a brief resource guide (published in 
2015) that contains answers to pertinent ques-
tions about PrEP, its use, and implementation. 
The guide can be downloaded at http://www.
unaids.org/en/resources/documents/2015/
Oral_pre-exposure_prophylaxis_questions_and_
answers. The information given should cover who 
is eligible to take PrEP, route of administration, 
frequency of use, side effects, and the need for 
HIV testing. 
4  ■  Building evidence to guide PrEP introduction for adolescent girls and young women 
STRUCTURE OF THE 
DOCUMENT 
This guidance document is divided into five sec-
tions, as follows:
Section 1: Provides a framework for PrEP intro-
duction to AGYW.
Section 2: Focuses on the key actors that influ-
ence AGYW’s choices—AGYW themselves, service 
providers, male partners, parents and guardians, 
and policy makers, respectively. For each type 
of actor, the section provides a brief rationale 
to reaching this key actor, important domains to 
investigate for guiding PrEP introduction, recom-
mended data collection methods, and illustrative 
questions per domain. 
Section 3: Describes additional data collection 
techniques and methods to gain a deeper per-
spective of participants’ views.
Section 4: Provides practical advice for conduct-
ing analysis. 
Section 5: Provides an overview of practices to 
foster research utilization. 
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SECTION 1  
DEVELOPING A PREP INTRODUCTION 
STRATEGY FOR AGYW:  
A CONCEPTUAL FRAMEWORK
sessment of these factors will determine whether 
health systems have the capacity to deliver PrEP 
safely and effectively to AGYW. 
The left side of the framework focuses on the 
main factors that determine whether young wom-
en are able to make informed decisions around 
PrEP uptake and its effective use. Key factors 
that influence informed choice, uptake, and use 
of PrEP include the community context, family 
dynamics, partner dynamics, and AGYW charac-
teristics. For instance, broader community-level 
knowledge about PrEP, parental consent for PrEP 
use, and experiencing violence within sexual rela-
tionships are likely to influence AGYW’s decisions 
about PrEP. Further, young women’s access to ed-
ucation, information, and social support, and their 
own HIV risk perceptions are likely to significantly 
influence PrEP uptake and use. Examining these 
factors will highlight key barriers and facilitators to 
PrEP uptake, use, and adherence among AGYW. 
The two sides of the framework are connected to 
illustrate the interplay between them, which we 
need to fully understand if PrEP for AGYW is to be 
realized. AGYW and service providers are depicted 
at the center of the framework to demonstrate the 
relative importance of  
provider-AGYW interactions. Consequently, it will 
be important to engage both service providers and 
AGYW in developing programs for PrEP introduc-
tion.
In this section we present a framework (Figure 
1, page 7) that highlights the range of players, 
relationships, and contextual factors that can 
affect AGYW’s health-seeking behaviors and their 
PrEP uptake and use. This framework is useful to 
consider when designing PrEP introduction strat-
egies. It positions young women in the context 
of their partner, peers, family, health providers 
and services, social values/community context, 
and broader scientific knowledge about PrEP—all 
of which can interact and influence, sometimes 
positively and sometimes negatively, the choices 
that AGYW make or are able to make. 2,10,13-17 
The framework consists of two sides that inter-
act, demonstrating the intricacies and dynamic 
aspects of PrEP introduction among AGYW. The 
right side of the framework focuses on the main 
factors that determine the feasibility of effective 
introduction of quality PrEP services for AGYW. 
These include the scientific context, political land-
scape, health system infrastructure, and provider 
dynamics. For instance, regulatory guidelines 
that identify target populations for PrEP can have 
major implications for who can access PrEP. 
Similarly, decisions around consumer drug costs 
and service delivery platforms can have import-
ant implications for AGYW. Service providers are 
gatekeepers of new medical products and their 
knowledge, attitudes, and perceptions will deter-
mine whether and how they offer PrEP to young 
women as an HIV prevention method. An as-
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The factors and relationships depicted in the 
framework extend beyond the initial phases of 
PrEP introduction and should be examined as 
part of ongoing efforts to monitor safety, adher-
ence, and service quality. 
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SECTION 2 
ENGAGING KEY ACTORS:  
KEY DOMAINS, METHODS, AND 
QUESTIONS
ADOLESCENT GIRLS AND  
YOUNG WOMEN
The success of PrEP as an HIV prevention inter-
vention among AGYW is largely dependent on 
its successful uptake and adherence by AGYW, 
the end-user of the drug. A critical assessment 
of AGYW’s knowledge, attitudes, perceptions, 
current sexual and reproductive health behaviors, 
social context, and engagement with the health 
care system will aid in identifying and reaching 
AGYW who are most at risk of acquiring HIV, de-
terming challenges associated with acceptance 
and uptake, and identifying opportunities to sup-
port AGYW in protecting themselves against HIV. 
The assessment needs to start with clarity 
around the AGYW sub-population to be reached. 
Once the focus AGYW group is decided, then the 
specific actors who might play a role in influenc-
ing those AGYW’s decisions about PrEP can be 
effecively identified.  
This section provides guidance on how to un-
dertake such an assessment to inform a PrEP 
introduction strategy for AGYW that reduces bar-
riers while enhancing facilitators to uptake and 
adherence.
Population
HIV vulnerability varies within the population of 
AGYW. For example, studies have shown that 
female sex workers (FSWs) are at a considerably 
higher risk of acquiring HIV when compared to 
the general AGYW population.18 The nature of the 
epidemic will determine relevant sub-populations 
of AGYW in a given setting. Program planners are 
encouraged to utilize existing epidemiological 
evidence and literature to identify the sub- 
populations who are the most vulnerable to HIV 
within their setting and who should be included 
in an assessment to understand the barriers and 
facilitators to uptake and adherence. 
An understanding of these sub-populations’ 
barriers and facilitators aids in tailoring a PrEP 
introduction strategy. See Box 1 for potential 
sub-populations to include in an assessment. 
Key Domains 
PrEP Attributes, Acceptability and Potential Use: 
There are several attributes of PrEP, such as fre-
quency and route of administration, side effects, 
and the need for frequent HIV testing, that may 
influence AGYW’s likelihood to use and adhere to 
it. Additionally, there is a need to assess AGYW’s 
attitudes and perceptions of PrEP after learning 
about how it works. The evidence shows that 
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users gain the greatest benefit of PrEP with very 
high adherence.4 Thus, understanding the fac-
tors, such as side effects, testing requirements, 
and drug supply, that are likely to influence ad-
herence are also important to assess. 
Risk Perception and Compensation: Using and 
adhering to PrEP is influenced by AGYW’s percep-
tions of their risk for acquiring HIV; if an AGYW 
believes she is at low risk of acquiring HIV, it is 
unlikely that she will access, use, and adhere 
to PrEP. On the other hand, there is concern 
that AGYW who perceive themselves at risk of 
acquiring HIV and do use PrEP, will increase 
risky sexual behaviors and reduce existing 
risk-reduction behaviors, which is known as “risk 
compensation.”19 There is little evidence of risk 
compensation, but understanding AGYW’s risk 
perceptions and potential for risk compensation 
prior to PrEP introduction can aid in developing 
BOX 1   
Potential sub-populations of 
AGYW
Female sex workers
AGYW who engage in transactional sex
AGYW who engage in cross-generational 
sex
AGYW with multiple concurrent partners
Married AGYW
Orphaned AGYW
Out-of-school AGYW
AGYW living in hotspots
AGYW with HIV-positive sexual partners
AGYW who perceive themselves to be at 
high risk of HIV acquisition
strategies to make risk salient to AGYW and maxi-
mize motivations for prevention.2
Gendered Power Dynamics: Inequitable gender 
norms and gendered division of power within 
sexual relationships have been shown to play an 
important role in AGYW’s ability to accept and 
adopt sexual and reproductive health interven-
tions, including contraceptive use and condom 
use.2,20 Thus, PrEP introduction strategies should 
take into account how gendered power dynamics 
and control over decision-making may influence 
perceived risks and benefits of PrEP, which im-
pacts uptake and adherence. 
Stigma and Social Acceptability: The willingness 
of AGYW to use and adhere to PrEP will greatly 
depend on social understandings, including 
whether it is seen as an effective, healthy option 
and a socially acceptable strategy for HIV pre-
vention.21 Additionally, stigma has been shown 
to influence PrEP uptake and adherence in a 
few studies because PrEP use might lead others 
to believe users are engaged in high risk sex or 
are HIV positive since PrEP is an antiretroviral.21 
Understanding PrEP-related stigma and social 
acceptability in a given setting is important for 
designing introduction strategies for AGYW.
Service Delivery Models and Strategies: The 
successful uptake of PrEP by AGYW will be 
dependent on the service environment where it 
is offered and whether AGYW feel comfortable 
accessing services from these locations. PrEP 
introduction strategies should consider the feasi-
bility of offering PrEP in diverse settings based on 
AGYW’s preferences. 
Methods
We recommend two methods to assess the 
challenges and opportunities associated with 
PrEP acceptance, uptake, and adherence among 
HIV-negative, sexually active AGYW: focus group 
discussions (FGDs) and in-depth interviews (IDIs).
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Use IDIs to gain information on topics that are 
sensitive in nature, such as power dynamics 
within sexual relationships, and when seeking 
information about personal perceptions, atti-
tudes, and behaviors. For each sub-population, a 
minimum number of IDIs is four to six. Program 
planners might also consider if groups should 
be conducted in various geographical regions in 
order to gain a broader overview of barriers and 
facilitators. 
Use FGDs to generate broad overviews of PrEP 
acceptance, uptake, and adherence to gain infor-
mation about social factors that would influence 
PrEP acceptance, and to brainstorm and gener-
ate ideas on how to increase acceptability and 
uptake. Consider conducting FGDs after a few 
IDIs have been completed to determine whether 
some themes from the IDIs are present within a 
larger group of AGYW. For each sub-population, 
an ideal focus group size is between 6 and 10 
participants and the assessment should include 
at least two to three groups of participants. 
Again, program planners might also consider if 
groups should be conducted in various regions in 
order to gain a broader overview of barriers and 
facilitators. 
Eligible AGYW are those who are HIV-negative. To 
draw the sample, purposefully select AGYW from 
a variety of settings where specific sub-popula-
tions are found in order to gain comprehensive 
information. Partnering with community-based 
organizations (CBOs)/nongovernmental orga-
nizatons (NGOs) who work with and are trusted 
by the different sub-populations of AGYW can 
provide detailed insights into where and how to 
recruit respondents. Healthcare settings, such 
as antenatal and family planning clinics, are one 
easily accessible location to recruit AGYW. AGYW 
recruited from these sites can also assist with 
the recruitment of their peers who might not 
access these services. Venues where AGYW are 
known to frequent can also serve as good recruit-
ment sites, such as CBOs, schools, youth clubs, 
markets, shopping centers, bars, clubs, and large 
community events. The staff of NGOs can provide 
insights into where sub-group populations, espe-
cially marginalized populations, such as young 
FSWs, could be reached. Another approach that 
works well with marginalized populations is snow-
ball recruitment or sampling. This entails the 
interviewers asking the participants of initial IDIs 
and FGDs to help connect them to their peers.
Ideally, FGDs and IDIs should be conducted 
by trained facilitators who are drawn from the 
participating sub-population or by individuals who 
can develop good rapport with participants, such 
as staff of CBOs. For breadth and depth, AGYW 
participating in IDIs should not participate in 
FGDs. Rather, the research team should assess 
the comfort level of each potential participant to 
determine whether to assign her to an FGD or an 
IDI. FGDs should be homogenous within sub-pop-
ulations of AGYW; that is, all participants for each 
FGD should be a member of the same sub-group 
(e.g., only FSWs should be in a FSW FGD). It is 
also important that FGDs and IDIs are conducted 
in safe spaces to ensure safety and confidential-
ity.
While these data collection strategies will in-
form how to effectively introduce PrEP to AGYW, 
continued monitoring of the domains after PrEP 
introduction will be needed to determine up-
take and adherence. As such, a monitoring plan 
should be developed.
Questions 
Note: Some of the questions noted below will not 
be appropriate for group discussions due to their 
sensitive nature. 
PrEP attributes, acceptability,  
and potential use
• Had you heard about PrEP before today? (If 
a FGD, ask for a show of hands and record 
number) If so, what had you heard, and who 
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or where did you hear it from? (Probe for 
health care provider, school, community-based 
educator, family/friends, PrEP user) 
• What do you see as the benefits of PrEP for 
you personally? 
  What about for other young women like 
you?
• In order for PrEP to work, people have to take 
a pill every day. What do you think about 
having to take a pill every day? 
  What do you think other young women like 
you would think about taking a pill every 
day?
• Another way that is currently being explored 
for people who want to take PrEp involves 
taking a series of pills right before having 
sex and then continuing to take pills shortly 
after having sex. What do you think about 
this method of taking PrEP, which provides 
protection just for that/those sexual 
encounter(s). Which of these ways are you 
more interested in, and why? 
  Of the two methods—taking a pill every day 
or taking it before/after sex—which method 
would you prefer, and why? 
  Which method do you think young women 
like you would prefer and why? 
• Based on what you learned today/have heard 
before, how would the following things about 
PrEP influence your decision and that of other 
young women like you about taking PrEP? 
(Facilitators can also lead the respondents 
through a listing and ranking exercise to 
identify major and minor concerns.)
  The level of effectiveness in preventing HIV 
transmission
  Having to take a pill every day 
  Possible side effects of PrEP (which ones?)
  Having to pick up a supply on a regular 
basis
  The requirement to be tested for HIV every 
two to three months 
  The requirement to receive counseling 
about adherence on a regular basis 
(adherence means taking medications in 
the correct amount, at the correct time, 
and in the way they are prescribed) 
  The color of the pill
  Having to store or keep the pills 
  The cost of the pill
  Any other concerns
• How would it make you feel to start taking 
PrEP? (Please describe) 
• Are there any cultural traditions in your 
community(ies) about taking medications that 
would make young women more or less likely 
to take PrEP? (Describe) 
• What if you were given something to motivate 
you to take PrEP?
• What should the incentive be? (Probe for 
money, airtime)
• If PrEP became available in your community 
in the next week, how willing would you be to 
start taking it immediately? 
• What if PrEP became available within the next 
six months, how willing would you be to start 
taking it immediately? 
• Earlier we talked about certain aspects 
of PrEP, including possible side effects 
and requirements to be tested, receiving 
adherence counseling, and picking up a pill 
supply on a regular basis. Do you think any of 
these things would make it more difficult to 
continue to take PrEP every day, over months 
or years? Which? (please describe)
• If you started to take PrEP, what would help 
you continue to take it every day, over months 
or years? (Probe and ask participants to rank 
from most to least helpful for: close location of 
PrEP services, support from partner, support 
from friends and family, other people you 
know taking PrEP, mobile phone text or call 
reminders, attitude of health facility staff, 
lower cost.) 
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• How easy or difficult do you think it would 
be to incorporate taking a daily pill into your 
current routine? Why?
• What factors would affect your ability to take 
PrEP on a daily basis? What factors would 
enhance your ability to adhere to a daily PrEP 
regimen? (Probe: product storage, dosing 
when away from home, peer support, other 
support measures like SMS reminders or 
adherence counseling, fear of others finding 
out or of GBV.)
Gendered power dynamics 
• Please tell me about instances where you 
have discussed avoiding/preventing HIV 
with your primary sexual partner? (Probe on 
condom use)
  Do you have additional sexual partners, 
and if so how many? 
  Does your primary sexual partner have 
other sexual partners (that you are aware 
of)? 
• How do your sexual partner’s opinions 
about you using products (e.g., condoms, 
contraceptives) to prevent HIV and pregnancy 
affect your decisions to use them?
• How might you discuss your desire to start 
taking PrEP with your sexual partner? 
• How would your primary sexual partner’s 
opinion about PrEP affect your decision to 
take it?
  What if he agrees? What if he disagrees?
  Is your sexual partner currently taking 
PrEP? 
• If you considered taking PrEP without telling 
your primary sexual partner, what impact 
might this have on your relationship? 
  How might he react if he found out?
• What would be some reasons why you would 
not tell your partner that you are interested in 
taking PrEP or you were taking PrEP?
Risk perception and  
risk compensation
• How likely do you think it is that you will get 
HIV? Why? (Probe for number and types of 
sexual partners, frequency of sex, condom 
use, knowledge of HIV status of partner) 
• How might your concerns about getting HIV, 
influence your interest in starting to take 
PrEP? 
• How might using PrEP change the type and 
number of sexual relationships you have? 
• How might the use of PrEP influence condom 
use with your sexual partners? 
Stigma and social acceptability
• What do you think your friends know about 
PrEP? How might their opinion about PrEP 
influence your decision to use PrEP?
• What do you think your parents/guardians 
know about PrEP? How might their opinions 
influence you? 
• What about other leaders in your community 
(e.g., teachers or religious leaders)? What kind 
of influence do they have on your opinions and 
decisions about PrEP?
• How do other people in your community think 
about ARVs and people who take ARVs? How 
do they treat people who take ARVs?
  In what way would these views influence 
your decision about whether to use PrEP (If 
so, how)?
• If you knew a friend was taking PrEP, what 
would you think of her?
• If you started to take PrEP, how likely would 
you be to share this information with your 
peers (or family members)? What factors 
would encourage/discourage you to do so? 
Service delivery strategies and models
• Where would you prefer to go for PrEP services 
and to collect PrEP pills? (Probe for health 
clinic, ARV clinic, youth-friendly clinic/service, 
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pharmacy, private provider, family planning 
clinic, NGO) What are the pros and cons of 
each place?
• What do you think about the idea of PrEP 
being delivered outside of a health facility 
(such as at school or at your home)? What 
might be the barriers and benefits to this 
different approach? 
• What is the best way to reach adolescent girls 
and young women with messages about their 
sexual health (Probe for radio, television, peer 
educators, health care providers, posters, 
flyers, social media, cell phone texts, etc.)?
• If you were going to create a campaign to 
encourage young women like yourself to 
consider using PrEP to reduce their risk of 
getting HIV, how would you describe what PrEP 
is and how it works (in your own words)? 
• What information about PrEP should be 
emphasized in communication campaigns? 
What should not be emphasized?
• For young women who start on PrEP, what is 
the best way to encourage them and remind 
them that they need to take the medication 
and to get tested for HIV every few months? 
(Probe for phone call reminder, text message 
reminder, letter)
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SERVICE PROVIDERS
Service providers of varying skill levels and 
service settings serve as the gatekeepers of 
new technologies requiring a prescription. PrEP 
introduction efforts depend on service providers 
and the health systems within which they work 
having the capacity to deliver the product safely 
and effectively to AGYW. A critical assessment of 
service providers’ knowledge, attitudes, beliefs, 
concerns, competencies, and behaviors is need-
ed in the following areas: 1) the introduction of 
a new technology into their service system and 
ability to provide quality care; 2) the introduction 
of an ARV-based product to AGYW; and 3) the pro-
vision of sexual and reproductive health services 
to AGYW in general. 
This section provides guidance on how to under-
take such an assessment to determine effective 
provision of quality PrEP services for AGYW. This 
assessment should provide insight into what 
strategies are needed for successful introduction 
and ultimately, uptake and adherence by AGYW. 
Population
The assessment should be conducted with appro-
priate cadres of service providers in a variety of 
health service settings to ensure appropriate 
counseling, provision, testing, resupply, and 
follow-up of AGYW. The assessment should gener-
ate insights from a variety of service providers 
who may be eligible to provide PrEP to AGYW. The 
selected providers will vary in a given setting. A 
potential list of service providers to include in the 
assessment is provided in Box 2.
It also is important to determine which service 
delivery settings would be most appropriate and 
feasible to reach different sub-populations of 
AGYW with PrEP. Therefore, service providers in-
cluded in the assessment should be drawn from 
the diverse service delivery settings that exist 
within a given context. A potential list of service 
settings is provided in Box 3. 
The information gathered from service providers 
and AGYW can help determine the feasibility of 
introducing PrEP, and if feasible, the best service 
delivery settings and service providers to provide 
PrEP. 
Key Domains
PrEP Knowledge, Attitudes and Perceptions: 
Recognizing the gatekeeper role that service 
providers play in influencing service delivery and 
uptake, it is important to assess their knowl-
edge, attitudes, and perceptions. Training on 
the technical aspects of PrEP introduction and 
use can be undermined by providers who hold 
negative attitudes and viewpoints toward PrEP. 
Existing research, mainly from developed country 
settings, shows that providers have a number of 
concerns that would influence their prescribing 
BOX 2 
Potential health service 
providers
Clinic administrators
Doctors and medical officers
Private medical practitioners
Nurses
Counselors
Lab technicians
Outreach workers
Pharmacists 
Peer educators
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of PrEP, including drug resistance, drug-related 
toxicities, the potential for funds to be diverted 
from HIV-related behavior change programs, and 
risk compensation.11,21 Thus, the findings from an 
assessment will help program planners deter-
mine the providers’ training needs to make PrEP 
introduction effective.
Stigma: Stigma from service providers within ser-
vice delivery settings is an important component 
to assess and understand.21,22 The contraception 
literature shows that service providers serve as 
barriers to uptake and use because many refuse 
to counsel about and provide contraception to 
adolescents due to their attitudes and beliefs 
about adolescent sexual activity.22 Therefore, it 
will be necessary to address stigma within ser-
vice delivery settings to reach and protect AGYW 
if PrEP introduction is to be feasible and success-
ful. A failure to assess and subsequently address 
service providers’ biases can significantly impede 
AGYW access and uptake of PrEP. 
Legal and Ethical Considerations: There are 
many ethical and legal considerations that must 
be assessed so that those at high risk of acquir-
ing HIV and most likely to benefit from PrEP can 
access this promising intervention. For exam-
ple, in some settings adult consent is required 
in order for adolescents under the legal age of 
consent to receive certain HIV services and treat-
ment; PrEP is likely to be included in the list.10 
The breach of the child’s right to confidentiality 
and access to care (as many vulnerable youth do 
not feel comfortable disclosing their behaviors to 
adults) are among the ethical concerns surround-
ing the need for adult consent. Safety is both 
a legal and ethical concern as some behaviors 
are illegal (e.g., selling sex) and AGYW may avoid 
accessing services. Another example is the obli-
gation of service providers to report adolescents 
who are below the legal age of consent request-
ing PrEP or to report behaviors of adolescent key 
populations in settings where certain behaviors 
are illegal.10 Therefore, service providers’ knowl-
edge of existing consent laws and other legal 
considerations, how they interpret and imple-
ment laws, how existing laws affect the provision 
of services to AGYW. 
Service Delivery Considerations: PrEP introduc-
tion and ultimately the potential benefits it may 
offer to AGYW may be severely undermined if 
health services lack the capacity and the ability 
to meet the technical requirements of PrEP.11,22 
These include the existence of written medical 
guidelines, protocols, and standards at the ser-
vice delivery sites; the possession of necessary 
equipment and supplies (e.g., HIV test kits); exis-
tence of adequate space to store products; and 
having the human resources to provide PrEP. It is 
also important to gain service providers’ insights 
BOX 3 
Potential service settings for 
delivering PrEP
Public-sector health centers and hospitals
Private medical practice health centers and 
hospitals
Non-governmental organizations
Faith-based organizations
University-based health clinics 
Youth-friendly health service locations
HIV counseling and testing sites
STI prevention and treatment sites
Family planning & reproductive health sites 
Maternal health settings
Pharmacies
Gender-based violence counseling sites
Mobile health services
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into which service delivery settings are most ap-
propriate and prepared to provide PrEP to AGYW 
to increase likelihood of acceptance, uptake, and 
adherence.
Service Access and Quality of Care: Provid-
er-patient interactions influence service access 
and quality of care provided. Adherence is a 
particularly challenging aspect of PrEP and 
there is need to develop strategies to effective-
ly support and measure adherence.11 Provider 
counseling of AGYW on correct and consistent 
use of PREP is a key strategy for fostering ad-
herence.23,24 Therefore, the existing capacity of 
service providers and service delivery systems 
to provide high quality counseling needs to be 
assessed. These results will inform the training 
of providers, and can be particularly helpful in 
dissipating providers’ reluctance to adopting new 
interventions that require special counseling and 
educational skills they do/may not possess.23,24 
Outside of counseling, a general assessment of 
how providers interact with AGYW is important to 
understanding how to improve the quality of care 
provided. To create the most effective training, 
the assessment should solicit providers’ insights 
into the best counseling messages for AGYW and 
their own training needs.23 
Methods
We recommend two strategies to assess the 
capacity of health care providers within different 
service delivery systems for PrEP introduction 
and roll-out: IDIs and surveys. Use IDIs to gain 
information on individual service provider’s 
knowledge, attitudes, beliefs, concerns, per-
ceived competencies, and experiences providing 
care to AGYW in a variety of health service 
settings. IDIs are preferred to FGDs because they 
allow for the exploration of sensitive (e.g., person-
al beliefs about adolescent sexuality, experiences 
with youth clients) and non-sensitive (e.g., ser-
vice delivery staff requirements for PrEP) topics. 
Furthermore, the interviews can provide in-depth 
information on factors relevant to distinct ser-
vice delivery settings, such as client flow, patient 
intake systems, and referral mechanisms. A 
minimum of two to three IDIs should be conduct-
ed per service provider type per service delivery 
setting type. Program planners must also consid-
er regional variations.
One good option is to recruit and train service 
providers currently offering HIV services to facili-
tate the IDIs because they will be knowledgeable 
and aware of the critical issues in HIV preven-
tion in their country. Being interviewed by peers 
who understand their daily experiences will also 
encourage service providers to be honest about 
their perspectives of PrEP. To encourage service 
providers to participate in the interviews, ensure 
confidentiality of their responses by anonymizing 
their transcripts and assure them that responses 
provided will not jeopardize their employment.
To complement the richness of the IDIs, the 
assessment should also include a survey ad-
ministered to a large cross-section of service 
providers in a variety of service delivery settings. 
The survey should collect information on many 
of the same topics covered in the IDIs. Consider 
conducting the survey after the IDIs are complet-
ed so that the survey design is informed by the 
results from the IDIs. It will also allow program 
providers to determine whether the findings from 
the IDIs are present in a larger sample of provid-
ers. Given that this population is likely to have 
high literacy levels, surveys can be self-adminis-
tered. The sample size for the survey will depend 
on the number of facilities capable of offering 
PrEP and the number of providers at these sites 
in each region of interest to program planners. 
One option is to administer the survey to all 
providers within a selected number of facilities. 
However, consult with a statistician to determine 
the sample size needed in order for findings to 
be generalizable to a type of service provider and 
service deliver setting.
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After the assessment, program planners should 
consider conducting a one to two day workshop 
with service providers from a variety of service 
delivery settings to discuss the findings from 
the IDIs and survey. This format is conducive to 
building consensus among service providers on 
the feasibility of PrEP introduction and allows 
participants to work together to develop locally 
grounded strategies to build capacity for offering 
PrEP. Participants can be divided into breakout 
groups to discuss questions about PrEP that 
arise. A note taker for each group is important 
to record all main points. Following the breakout 
sessions, groups should be brought back togeth-
er to report on their discussion and start the 
consensus building process.
Questions
A 2012 consultation led by the Population Coun-
cil on “Shaping the operations research agenda 
for antiretroviral-based prevention products for 
women” identified several important domains for 
operations research relevant to PrEP and service 
providers, including service delivery models, 
programs and services; providers; type and 
training; HIV testing and retesting; and potential 
resistance. Several questions presented below 
are drawn from this document. We encourage 
program planners to access the document 
for more detailed information at http://www.
popcouncil.org/uploads/pdfs/2012HIV_Shapin-
gORAgendaARV.pdf.
We also encourage program planners to access 
another Population Council resource, “ARV-
based HIV prevention for women: State of the 
science and considerations for implementation 
in Zimbabwe. Report from a provider workshop,” 
to aid in designing a workshop with providers 
focused on PrEP and applicable questions that 
can be included. This resource can be down-
loaded at: http://www.popcouncil.org/uploads/
pdfs/2015HIV_ZimbabweProviderWorkshop.pdf.
Qualitative questions
PrEP knowledge, attitudes and perceptions
• What have you heard about PrEP? 
  Have you received any professional or 
technical guidance/training regarding 
PrEP, from the government or international 
organizations? (If yes, please describe)
• What do you see as the potential benefits of 
introducing PrEP? 
• What concerns, if any, do you have about 
introducing PrEP? (Probe on safety, efficacy, 
drug resistance, risk compensation) 
• Who should have access to this new 
intervention? 
  Which groups would most benefit from 
PrEP?
  For each group that would benefit, where 
and how would they best be reached?
• Would you feel comfortable prescribing PrEP? 
  How might you assess if a patient/client 
needs might be a good candidate for PrEP?
• What additional information would you need in 
order to feel comfortable prescribing PrEP?
• Based on your experiences, what are your 
opinions about making HIV PrEP available for 
AGYW? 
  How would you feel about prescribing PrEP 
to AGYW? 
  What do you see as the potential benefits 
of introducing PrEP for AGYW? 
  What are the drawbacks?
  What additional information would you 
need in order to feel comfortable providing 
PrEP to AGYW or certain subpopulations of 
AGYW?
• Under what circumstances would you 
prescribe PrEP to AGYW?
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Legal and ethical considerations
• What type of legal/ethical issues do you 
currently encounter when providing HIV 
or other types of sexual and reproductive 
services to adolescents and young adults? 
(Probe on sub-groups of AGYW such as FSWs, 
orphans, married AGYW) 
  How do you address these issues? 
  What actions should policy makers take to 
address these issues?
• If in the next year, the government endorsed/
provide PrEP, how would that influence your 
opinion of PrEP?
• What legal or ethical issues would consider in 
providing PrEP to young women? 
  How do national regulations regarding the 
provision of ARV-based medications to 
AGYW influence your work? 
• What are current parental consent laws 
around HIV services for young people? 
  How would this affect protocols for 
providing PrEP to AGYW at your clinic/
health facility?
  Under what circumstances should AGYW be 
able to consent for themselves? Why these 
circumstances?
  What kind of information do you think 
should be provided to partner(s) or 
parent(s)/guardian(s) of AGYW who are on 
PrEP or seeking PrEP?
  What is the obligation of the health care 
provider in reaching the AGYW’s sexual 
partner(s) or parent(s)/guardian(s)?
• How do you think community leaders would 
respond to the introduction of PrEP for AGYW? 
What about religious leaders or institutions? 
Schools? Other groups?
Service delivery considerations
• What do you consider appropriate service 
delivery settings to offer PrEP to AGYW?
• What cadre of staff (i.e., nurse, clinical officer, 
health worker) would best be able to screen, 
counsel, and prescribe PrEP to AGYW?
  At your clinic/health facility, what kinds of 
trainings might be needed on the provision 
of PrEP? And on being able to provide PrEP 
to AGYW?
• At your clinic/health facility, how would 
providing PrEP affect existing services in terms 
of client flow, operations, staffing, storage, 
etc.?
• What do you foresee as the key challenges 
providers may face in offering PrEP? And in 
offering PrEP for AGYW? 
• How can you support women’s use of the PrEP 
or other daily ARV-based medication? In what 
ways do you help women understand and 
manage potential side effects?
• How do you/your clinic, currently measure/
assess if clients are adhering to their ARV 
medications? 
  What challenges would AGYW face in 
adhering to PrEP?
• In your experience, what strategies have been 
effective for supporting adherence among 
PrEP users? 
• What are the storage implications for PrEP at 
the service delivery site? 
• What service model package is most effective 
for reaching various sub-populations of AGYW? 
• Which program entry points would be most 
effective to deliver PrEP?
  ARV-based prevention products will require 
counseling, HIV testing, and monitoring. 
Which service settings might afford good 
opportunities for delivering PrEP? (Probe on 
existing settings in the country) 
Service access and quality
• What are the main challenges that AGYW 
might face in getting access to PrEP? 
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• How well do you feel your clinic/health facility 
is currently doing in providing the following 
services, and for each, how can service 
delivery be improved?
  Quality of care overall
  Quality of care for HIV-positive patients on 
ARVs
  HIV testing and counseling
  Adherence counseling, for ARVs and other 
regimes requiring adherence
  SRH services for adolescents
  Welcoming and comfortable environment 
for AGYW
• If PrEP was introduced in the country, how 
do you think this would affect existing HIV 
prevention and treatment programs and the 
health system more broadly? (Probe on HIV 
testing programs, HIV treatment programs, 
sexual and reproductive health programs/
services, staff deployment, task-shifting)
• Are there lessons (positive and negative) from 
the introduction of other technologies or HIV 
prevention strategies that could inform plans 
for introducing PrEP?
• Are there lessons (positive and negative) from 
other HIV prevention programs with AGYW that 
could inform plans for introducing PrEP for 
AGYW?
• In your opinion what might be the best way 
to create demand among AGYW for this new 
product?
Stigma
• Who do you consider to be the most at risk for 
HIV? Why? (Probe on AGYW and sub-groups)
• How well do you think AGYW are able to 
assess their level of HIV risk? How do you 
counsel youth clients who think they are at 
high risk of HIV?
• How do providers currently view AGYW who 
take ARVs? Does this differ by the client’s 
age? How they acquired HIV? Reported sexual 
activity? 
• Why might community groups have negative 
reactions to providing PrEP to AGYW? 
• Why might health care providers have negative 
attitudes about providing PrEP to AGYW?
• How would you describe your feelings about 
prescribing PrEP to AGYW? Would this differ by 
the client’s age (girls age 10–14 vs. 15–19 vs. 
20–24), and if so, how?
• How do you think you would react if an AGYW 
client requested PrEP?
Quantitative questions
The quantitative survey should collect provider 
demographic information to assess whether PrEP 
knowledge, attitudes, and experiences differ by 
provider demographics, such as age, gender, 
medical training, facility type, experience caring 
for HIV-positive patients, or perceived HIV risk. 
PrEP knowledge, attitudes and perceptions/
stigma
Response categories for the following questions 
are: (a) strongly agree; (b) agree; (c) neutral; (d) 
disagree; and (e) strongly disagree.
Provider attitudes and perceptions about 
PrEP in general 
Note: The questions in this section were adapt-
ed from Mimiaga MJ, et al. 2014. “Suboptimal 
awareness and comprehension of published 
preexposure prophylaxis efficacy results among 
physicians in Massachusetts,” AIDS Care 26(6): 
684–693.30
1. There is not enough data on PrEP’s clinical 
efficacy
2. I am concerned about the potential side 
effects of PrEP
3. I do not have time to provide clinical 
monitoring
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4. I do not have time to engage in prevention 
counseling
5. The use of PrEP will cause patients to 
engage in riskier behaviors
6. The provision of PrEP will result in an 
increase in sexually transmitted disease 
incidence among patients
7. The use of PrEP will result in less frequent 
HIV testing among patients
8. Non-biomedical HIV prevention interventions 
(behavioral) are more effective than PrEP
9. Non-biomedical HIV prevention interventions 
(behavioral) are safer than PrEP
10. The use of PrEP for prevention will result in 
less funding for HIV treatment
11. Antiretrovirals for prevention will select for, 
and disseminate, drug resistance
12. Non-biomedical HIV prevention interventions 
(behavioral) should be attempted before 
prescribing PrEP
13. I am uncomfortable prescribing drugs for 
new indications unless there are many years 
of follow up data
14. I believe PrEP should be readily available to 
all persons at risk for HIV infection
15. I would provide PrEP to the following sub-
populations [record response for each]
a. High-risk men who have sex with men
b. Injection drug users
c. People with a sexually transmitted 
disease
d. People who change sex partners 
frequently
e. People who exchange sex for money, 
drugs or other goods
f. AGYW
g. Discordant couples
h. Any person who believes he/she is at 
high risk for HIV infection
i. Any person regardless of risk
Attitudes and perceptions about PrEP for 
AGYW
1. AGYW are at high risk for acquiring HIV 
2. PrEP should be readily available to AGYW
3. There are certain sub-populations of AGYW 
who are at high risk for acquiring HIV
4. PrEP should be readily available to certain 
sub-populations of AGYW 
5. The use of PrEP will cause AGYW to engage 
in riskier behaviors
6. Administering PrEP to AGYW would result in 
backlash from the community
7. Administering PrEP to AGYW would result in 
backlash from religious leaders
8. I would provide PrEP to the following sub-
populations of AGYW [record response for 
each]
a. AGYW with a sexually transmitted 
disease
b. AGYW who change sex partners 
frequently
c. AGYW who exchange sex for money, 
drugs or other goods
d. AGYW with an HIV-positive partner
e. Any AGYW who believes she is at high 
risk for HIV infection
f. Any AGYW regardless of risk
Stigma
1. Providing PrEP endorses the negative 
(sexual) risk behaviors of users
2. PrEP should not be given to AGYW because 
they should not be having sex
3. AGYW are not responsible enough to be able 
to adhere to PrEP
4. AGYW should be ashamed to ask their 
provider for PrEP
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5. Parents should be ashamed if their young 
daughters ask their provider for PrEP
Service Delivery Considerations/Service Access 
and Quality
1. What do you consider appropriate service 
settings to deliver PrEP to AGYW? [Check all 
that apply]
• Public sector health centers
• Private health centers
• Non-governmental organizations
• Faith-based organizations
• Youth-friendly health service locations
• HIV counseling and testing sites
• STI prevention and treatment sites
• Family planning and reproductive health 
sites
• Maternal health settings
• Gender-based violence counseling sites
• Mobile health services
• Other [please write] 
Checklist for service delivery readiness
Note: The questions below can be thought of as a 
checklist to determine the readiness of a service 
delivery site to introduce PrEP for AGYW.
Please respond to the following statements, 
thinking about your own service setting/facility. 
Response categories for the following questions 
are: (a) strongly agree; (b) agree; (c) neutral; (d) 
disagree; and (e) strongly disagree.
1. Written medical guidelines, protocols 
and standards for ARV-based prevention, 
including PrEP, are available at this site
2. Providers have been trained in the provision 
of PrEP to AGYW
3. Providers have job aids and information, 
education and communication materials 
to provide information about PrEP that are 
appropriate for AGYW
4. Providers counsel clients about HIV testing 
and repeat testing, HIV prevention options, 
including male and female condoms, and 
provide instructions on use, side effects and 
follow-up required
5. Providers emphasize the importance of 
condom use as the best available means for 
HIV prevention and encourage use of male 
and female condoms along with PrEP
6. Facilities have the necessary equipment and 
supplies to provide PrEP (including HIV test 
kits, PrEP, male and female condoms, other) 
and have a system to prevent stock outs
7. The facility provides a private space for 
confidential HIV testing and counseling 
on PrEP use, and providers ensure client 
privacy and confidentiality
8. Providers tailor interactions to each AGYW’s 
particular needs, circumstances and 
concerns 
9. Providers treat AGYW with dignity and 
respect; they are non-judgmental and 
sensitive to gender differences and power 
imbalances
10. Providers use language that clients, 
including AGYW, understand, assess 
knowledge gaps, and encourage questions 
to check comprehension of information 
provided
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MALE PARTNERS OF AGYW
Engaging male partners of AGYW is important in 
understanding the likelihood of PrEP acceptance, 
uptake, and adherence by AGYW. Gender norms 
and the gendered division of power often result 
in male partners exerting influence over women’s 
decisions about their sexual and reproductive 
health. Therefore, PrEP introduction efforts need 
to engage AGYW’s male partners to understand 
the norms and decision-making processes within 
their relationships, their knowledge and percep-
tions of PrEP, and their attitudes and concerns 
toward AGYW’s use of PrEP. 
Population
Men’s influence on women’s decision-making 
processes regarding their sexual and reproduc-
tive health differs by partner type. Research from 
several microbicide trials found that women re-
ported better adherence and greater ease using 
products discretely with “casual,” transactional, 
and non-cohabitating partners compared to 
steady/main partners.25 Given the challenges of 
using HIV prevention interventions in more stable 
partnerships, we recommend that husbands, co-
habitating partners, and boyfriends be the focus 
of the assessment. 
Key Domains 
PrEP Attributes, Knowledge and Perceptions: 
One of the reasons why men might be opposed 
to their partners using sexual and reproductive 
health products is their concerns about product 
safety.25 Resistance is also fueled by lack of 
knowledge about the product. Therefore, ef-
forts should be made to elicit their opinions and 
perceptions regarding PrEP, which can aid in tai-
loring messages that gain men’s support of their 
partners’ use of PrEP.23 
Gender Norms and Power Dynamics: Research 
shows that prevailing gender norms about 
sexuality and relationship dynamics affect how 
women make decisions about the use of sexu-
al and reproductive health products, including 
microbicides, condom use, and contraceptive 
use.2,20,22,23,25 For example, partner opposition 
has been identified as an important reason 
for contraception misuse and that emotional, 
physical, and sexual violence within relation-
ships significantly reduces contraceptive use 
and continuation.22,25 Furthermore, the choice 
to use sexual and reproductive health products 
could have a negative impact on the relationship 
because some men may equate their usage with 
infidelity.25 Program planners should assess how 
gender norms and power dynamics influence 
men’s acceptance and support of their partner’s 
use of PrEP. 
Methods
We recommend the use of IDIs to gain informa-
tion on male partners’ knowledge, attitudes, 
beliefs, and concerns about PrEP and their 
partners’ use of it. IDIs are preferred due to the 
sensitive nature of the questions. A minimum of 
four to six IDIs should be conducted per relation-
ship type—married, co-habitating, and boyfriend. 
IDIs should consider the HIV status of the male 
partner, as HIV positivity may influence men’s 
attitudes toward PrEP. Program planners must 
also consider regional variations which require a 
similar number of IDIs for each distinct area.
Recruiting a selection of male partners could 
be done through their female partners (though 
there are ethical challenges to consider), through 
community groups, and through locations where 
they are known to frequent (e.g., local bars or 
work venues). One type of location to find AGYW 
who might have a steady/main partner is health 
care settings, especially antenatal care and 
family planning service locations. AGYW might be 
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  Which groups would most benefit from 
PrEP? 
  For each group that would benefit, where 
and how would they best be reached?
• What are the best ways to engage men 
regarding PrEP?
  What information should be included in 
education and sensitization campaigns 
about PrEP geared toward male partners?
• What about you, are you interested in taking 
PrEP? Why or why not?
• What do you think about AGYW having access 
to PrEP?
Gender norms and power dynamics 
• Please tell me about instances where you 
have discussed avoiding/preventing HIV 
with your primary sexual partner? (Probe on 
condom use, male circumcision)
• How do you think your opinion affects the 
decisions your sexual partner makes about 
using products to prevent HIV and pregnancy, 
such as condoms or contraceptives?
• How might you discuss your desire to start 
taking PrEP with her? 
• If your sexual partner told you that she wanted 
to take PrEP, what would be your reaction? 
  What would you do?
  What would say? Would you support her
  How would your opinion affect her decision 
to take PrEP? 
  What are the best ways for your partner to 
engage you about her desire to take PrEP? 
• What would be some reasons why your sexual 
partner would not tell you she was interested 
in taking PrEP or she was taking PrEP?
• If you found out that your sexual partner was 
taking PrEP and she had not told you, what 
would be your reaction?
  What would you do?
able to directly recruit their partners or they can 
provide the locations (e.g., home address) where 
to reach them. It is vitally important that program 
planners make sure that AGYW are comfortable 
recruiting their male partners or providing infor-
mation. Another avenue to recruit male partners 
is to directly approach them in locations where 
they are known to frequent. These locations can 
be identified through their female partners and 
from key informants, such as staff at NGOs who 
work with men and are knowledgeable of the 
local scene. HIV-positive male partners can be 
recruited through health services, such as those 
offering services to discordant couples.
Recruit and train male facilitators from the region 
where the IDIs will take place because they will 
be knowledgeable and aware of the gender 
norms and beliefs in that area. Furthermore, 
being interviewed by peers who are familiar 
with local norms will build rapport between the 
facilitator and participants, encouraging honest 
answers from participants. 
Questions
PrEP attributes, knowledge, and perceptions 
• Had you heard about PrEP before today? If 
so, what had you heard, and from who or 
where did you hear it? (Probe for health care 
provider, friend, community-based educator, 
PrEP user) 
• Based on what you learned today/have heard 
before, what are your thoughts about PrEP? 
  What concerns do you have about PrEP? 
(probe on safety, stigma, taking a drug if 
HIV-negative, side effects, relationship 
concerns, community influences)
  What questions do you have about PrEP?
• Who do you think should have access to this 
new intervention? 
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  What would you say?
• If your partner decided to take PrEP, what 
impact might her decision have on your 
relationship?
• If your partner wanted to take PrEP, what can 
be done to gain your support for her decision? 
• If your partner decided to take PrEP, what 
things would you do to support her decision?
  Would you participate in drug-adherence 
counseling? Why or why not?
  What are the main barriers to you 
accompanying your partners to the clinic for 
PrEP?
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PARENTS AND GUARDIANS OF 
AGYW
Parents’ and guardians’ knowledge, attitudes, 
and perceptions about PrEP may directly influ-
ence those of AGYW. This is particularly important 
to examine in places where the ability to use 
PrEP by AGYW under the legal age of consent is 
dependent on obtaining a parent’s or guardian’s 
consent. Obtaining parental or guardian consent 
can be a significant barrier, either because they 
cannot be reached or because they may decline 
consent. To determine the feasibility of PrEP for 
AGYW, especially those who are under the legal 
age of consent for medical treatments (which 
varies by country), this section provides guidance 
on engaging parents and guardians in the as-
sessment process. 
Population
AGYW reside in different types of family struc-
tures, where guardians might have varying 
opinions about their use of medical interventions. 
Research shows that family structure influences 
adolescent beliefs as well as health and educa-
tion outcomes.26,27 Understanding how different 
type of guardians view PrEP for AGYW will aid in 
tailoring introduction strategies. Examples of fam-
ily structures to consider appear in Box 4. 
Key Domains 
PrEP Attributes, Knowledge and Perceptions: 
Parents and guardians may be reluctant to 
provide consent for their adolescent to take PrEP 
because they lack knowledge about it and have 
safety concerns related to taking the drug.28 With-
out proper information, they might overestimate 
the risks of adverse health events associated 
with taking PrEP. Efforts should be made to 
educate parents and guardians about PrEP and 
its attributes, especially information about safety, 
and elicit their opinions regarding PrEP. This infor-
mation can aid in tailoring messages that foster 
parents’ and guardians’ support for PrEP.
Stigma and Social Acceptability: As previously 
noted, the willingness of AGYW to use and adhere 
to PrEP will greatly depend on social understand-
ings, including whether it is seen as an effective, 
healthy, and socially acceptable strategy for HIV 
prevention among AGYW.21 Parents’ and guard-
ians’ understanding and acceptance of PrEP may 
play a key role in providing AGYW with support or 
formal consent to take PrEP, as well as influence 
AGYW’s uptake and adherence to PrEP. However, 
the stigma associated with taking an ARV med-
ication may result in parents’ and guardians’ 
reluctance to provide their consent. Parents may 
be concerned about the backlash their child and 
their entire family might face (e.g., belief that 
their child is HIV-positive) if the community finds 
out and is not accepting of PrEP.28 Introducing 
PrEP to AGYW, especially those under age 18 (or 
the legal age of consent), requires understand-
ing the role of stigma and acceptability from the 
perspective of parents and guardians. 
Legal and Ethical Considerations: Many ethi-
cal and legal considerations pose a significant 
BOX 4 
Potential family structures
Two parent households
Single parent households
Grandparent-headed households
Households headed by other relatives
Household headed by non-relatives
Households with orphans
AGYW living in government facilities 
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Questions
PrEP attributes, knowledge and perceptions 
• Had you heard about PrEP before today? If so, 
what had you heard, and who or where did 
you hear it? (Probe for health care provider, 
community-based educator, another parent or 
guardian, PrEP user) 
• Based on what you learned today/have heard 
before, what are your thoughts about PrEP? 
  What concerns do you have about PrEP? 
  What questions do you have about PrEP?
• Who do you think should have access to this 
new intervention? 
  Which groups would most benefit from 
PrEP? 
  For each group that would benefit, where 
and how would they best be reached?
• What do you thinking about adolescents 
and young people having access to this 
intervention? Should PrEP be a choice for 
youth?
  What about girls? 
  At what stage in life do you think girls 
should be able to access PrEP?
  What about boys? 
• Have you ever discussed HIV prevention with 
your sons or daughters? 
• If your daughter wanted to take PrEP or you 
found out that your daughter was taking PrEP, 
what would be your reaction to this news? Why 
would this be your reaction?
Stigma and social acceptability 
• Who do you consider to be the most at risk for 
HIV? Why?
  What about AGYW and sub-groups (List 
the various sub-groups of AGYW if not 
discussed)
challenge to providing PrEP to AGYW. The need 
for adult consent in some settings may act as a 
deterrent for AGYW in accessing health services 
due to the need to disclose their behaviors to 
their parents or guardians.10 However, a prevail-
ing question is whether parents and guardians 
think it is necessary for them to provide consent. 
Even if parents and guardians think their con-
sent is necessary, there might be circumstances 
in which their consent can be waived. There is 
a need to understand these ethical and legal 
complexities from the viewpoint of parents and 
guardians if PrEP will be feasible for AGYW under 
the legal age of consent. 
Methods
Use FGDs to elicit in-depth information on par-
ents’ and guardians’ knowledge, attitudes, and 
perceptions about PrEP and considerations 
around providing consent for their adolescent 
child to use PrEP. For each chosen family struc-
ture type, an ideal focus group size is between 6 
and 10 participants, with at least 2–3 groups of 
participants. Program planners must also con-
sider if groups should be conducted in various 
regions, which will require a similar number of 
FGDs (one to two) per chosen area. It is rec-
ommended that trained facilitators from the 
community conduct the FGDs because these 
individuals will be knowledgeable of local norms 
and will be able to build rapport with parents. 
One avenue for reaching parents is through 
institutions that service adolescents and/or 
guardians, such as schools, churches, and social 
service organizations. For example, teachers 
in schools can provide information on potential 
guardians to recruit. Another avenue is to part-
ner with local NGOs who work with families or 
are familiar with families in their communities. 
The staff of these organizations can identify the 
households and aid in recruitment. 
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• What do you think parents like yourself think 
about adolescent girls who engage in sexual 
activity?
• Do you think AGYW are able to assess their 
HIV risk? 
• How do other adults in the community, who 
are like you, view AGYW who take ARVs 
currently? 
  How would you think they would view those 
who take PrEP?
  How do you think they would view you if 
they knew your child was taking PrEP?
• Sometimes, people who are taking ARVs face 
negative attitudes or reactions from health 
care providers or from other community 
members; what drives these attitudes or 
reactions? 
  What might be the best way of addressing 
these issues to reduce negative attitudes 
and reactions?
• If your daughter wanted to take PrEP or you 
found out that your daughter was taking PrEP, 
what would be your reaction to this news? Why 
would this be your reaction?
• If your daughter wanted to take PrEP or you 
found out that your daughter was taking PrEP, 
what kind of support would you offer to her?
  Would you be willing to attend adherence 
counseling with your adolescent? Why or 
why not?
• What should be done to inform parents about 
PrEP? What will gain your support if you are 
reluctant about your daughter taking PrEP?
  What information should be included in 
education and sensitization campaigns 
about PrEP geared toward parents?
• What cultural traditions might impact AGYW 
decision to use PrEP? How about to not use 
PrEP? 
Legal and ethical considerations
Note: These questions should be tailored based 
on the legal and ethical guidelines within each 
country.
• Currently, parents/guardians must give 
adolescents under the age of [insert relevant 
age] their permission to access [insert 
relevant services] and use [insert relevant 
products]. Under what circumstances do you 
think parents in your community would give 
their adolescents permission to access these 
services or use these products? 
  What has been your other parents’ 
experience with offering permission for 
services?
• Currently, parents/guardians must give 
adolescents under [insert relevant age] their 
permission to access [insert relevant services] 
and use [insert relevant products]. If policy 
makers decide that adolescents no longer 
require parental permission to access these 
services or use these products, what would 
be your reaction? Why would you have such a 
reaction?
• What about PrEP, do you think parental 
permission should be required in order for 
adolescents to use PrEP? Why or why not?
• Under what circumstances do you think 
that your adolescent does not need your 
permission to access [insert relevant services] 
and use [insert relevant products]? What 
about PrEP, specifically?
• If your daughter wanted to take PrEP, would 
you be willing to give your permission for her 
to take it?
  What are the main reasons why you would 
not give your consent? 
  What are the main reasons why you would 
give your consent?
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POLICY MAKERS
Understanding policy makers’ awareness, at-
titudes, perceptions, and preferences around 
PrEP is very important in guiding its introduction 
and roll-out. It is also important to understand 
their vision for how PrEP fits into the overall HIV 
prevention landscape in their countries and their 
opinions about drug availability, prioritization of 
populations, settings for PrEP roll-out, tailoring 
services to foster effective uptake of PrEP, and 
ensuring adherence.4 
To engage policy makers around PREP and 
AGYW, we recommend the toolkit, “Introducing 
antiretroviral (ARV)-based prevention products 
for women: a guide to strategic decision-mak-
ing and planning.” With the support of USAID/
Washington, the Population Council developed 
the toolkit (http://www.popcouncil.org/uploads/
pdfs/2015HIV_ARVtoolkit.pdf) for use by govern-
ments, organizations, and donors that are in a 
position to support or add new HIV prevention 
products into existing programs. This toolkit is 
based on the belief that women should have 
access to a wide range of options to prevent 
HIV and have the ability to choose those that 
best meet their needs. The toolkit was piloted in 
Zimbabwe and a document containing the results 
along with additional resources can be down-
loaded at http://www.popcouncil.org/uploads/
pdfs/2015HIV_ZimbabweProviderWorkshop.pdf. 
Box 5 summarizes three of the toolkit’s modules. 
BOX 5 
Toolkit modules
Module 1. Landscape analysis 
An analysis of the epidemiologic context of the HIV epidemic, along with an HIV policy and 
program scan. The analysis consists primarily of a desk review of available literature and data, 
supplemented as needed with input from experts familiar with the HIV epidemic and the specific 
country context. It serves as a starting point and foundation for the process in Modules 2 and 3. 
Module 2. Discussion guide for key opinion leaders and decisionmakers 
A guide to conducting IDIs with a select group of key decision makers who will be involved in 
or influence strategic decisions about the introduction and roll-out of PrEP. Key domains to 
cover with opinion leaders and policy makers include: scientific evidence and data needs; 
target population and priorities; impact on health systems; policy considerations; economics, 
cost, and financing; and decision-making. IDIs should be conducted by a senior leader who is 
knowledgeable about both HIV prevention and the country’s policy environment. Results will 
provide an indication of the strategic role PrEP could play within a country’s HIV prevention 
program and help determine how best to continue to explore and plan for introduction. 
Module 3. Program planning guide 
The guide is to be used with policy makers, service providers, and program managers who 
are responsible for implementing HIV prevention programs. The module guides workshop 
participants to consider the feasibility of introducing HIV prevention tools in specific facility-based 
settings by guiding them through a series of design considerations to determine opportunities 
and challenges in service setting(s) that should be addressed in program planning. 
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In this document we propose the use of FGDs 
and IDIs. FGDs involve a small group of indi-
viduals who share common characteristics or 
experiences related to the topic of interest.33 
The group dynamic allows for brainstorming to 
generate insights and strategies, provides infor-
mation on social context such as norms, and gain 
insights into social interactions. IDIs, on the other 
hand, are one-on-one discussions between a par-
ticipant and an interviewer.34 The interview can 
be semi-structured with open-ended questions 
or unstructured allowing the participant to freely 
discuss the topic. IDIs provide rich, detailed infor-
mation from participants about their experiences, 
opinions, and behaviors. They are particularly 
useful for sensitive and complex subjects. Key 
informant interviews are IDIs with people who are 
knowledgeable about what is going the commu-
nity.
PARTICIPATORY TECHNIQUES
As part of FGDs and IDIs, there are additional 
techniques that can be used to get more insight 
into participants’ views:
1. Card-sorting involves creating a set of cards 
with descriptions about a topic, problem, 
behavior, or product. The descriptions can 
be pictorial or text. The cards are given to 
the participant who is asked to sort them 
in a particular order. For example, the 
researcher might ask AGYW to sort cards 
on PrEP characteristics and attributes 
according to what most concerns them 
about PrEP or what would most influence 
their decision to take PrEP. After the 
sorting is complete, the researcher can ask 
participants questions to further explain 
their thought process for the order they 
selected. Card-sorting can be incorporated 
into qualitative study designs previously 
discussed. For example, participants can 
complete a card-sorting activity at the end of 
the FGD.
2. Vignettes are stories created by researchers 
about individuals and situations to help 
elucidate participants’ perceptions, beliefs 
and attitudes about a topic under study.35,36 
The premise of the stories comes from 
a range of sources, including previous 
research findings, research participants, and 
information from key informants in the field 
such as NGO staff working with the research 
population. It is important that the vignettes 
are relevant and real to the participants. 
The vignettes are presented to participants, 
who are asked to respond to a range of 
questions about what they have heard, 
including what they would do in a particular 
situation or how they think another person 
would respond. It is particularly useful 
when interviewing young children and 
adolescents. One of the key limitations is 
that vignettes cannot account for what a 
SECTION 3 
ADDITIONAL DATA COLLECTION 
METHODS 
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participant will actually do in real life but it 
is helpful for unpacking perceptions, beliefs, 
and attitudes on a wide range of social 
issues. 
OBSERVATIONS
Observation involves the careful and systematic 
documentation of events and behaviors in the so-
cial setting chosen for study. The observer makes 
detailed field notes that are nonjudgmental and 
concrete in descriptions.37,38 Notes should include 
descriptions of actions and interactions among 
individuals as well as non-verbal cues such as 
body language and facial expressions. After 
initial observations, checklists can be created to 
assess the presence or absence of a phenome-
non. One limitation to this method is reactivity by 
those being observed; individuals might change 
their behaviors when they know they are being 
observed. One solution is to visit the site for a few 
days before data collection to reduce reactivity.
Program planners can directly observe the clin-
ical settings in which PrEP is likely to be offered 
as well as current interactions between providers 
and AGYW patients to understand service de-
livery areas that work well and areas requiring 
improvement. For example, observing interac-
tions surrounding contraceptive use can serve as 
a proxy for PrEP. This information can be used to 
prepare a clinical setting for PrEP introduction, 
such as trainings of health care providers. Fol-
lowing the introduction of PrEP, observations can 
be conducted to understand how well the setting 
was prepared, successful implementation strate-
gies, and ongoing challenges. 
MYSTERY CLIENT METHOD
The mystery client (or shopper) method involves 
researchers posing as prospective clients in 
order to evaluate client experience when seeking 
services, such as health care.39-41 The meth-
od reduces the bias that can be introduced in 
observations; that is, where individuals change 
their behaviors because they know they are 
being observed. Mystery clients are individuals 
who possess the characteristics of the types of 
patients who would seek the service. Clients are 
trained to assume a specific role when seeking 
services and then report on their experience. 
Immediately following the visit, the client is 
interviewed using a checklist or interview guide 
in order to capture a detailed account about their 
experiences and interactions while in the facility. 
It is best that mystery clients do not come from 
the area where the clinical setting is located. The 
facility should be informed that mystery clients 
will visit the facility but not exact dates. For exam-
ple, facilities can be told mystery clients will visit 
within the next three months. 
Program planners can use mystery clients during 
PrEP introduction to monitor and evaluate service 
delivery, including patient-provider interactions, 
adherence to delivery protocols, and service 
quality. This method can provide detailed and 
useful insights into good practices and areas for 
improvement. 
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QUALITATIVE DATA
Analysis and interpretation of the qualitative and 
narrative data proposed in this guidance doc-
ument should provide unique insights that can 
assist in determining the feasibility of introducing 
PrEP to AGYW and if feasible, the development, 
design, and implementation of PrEP introduction 
strategies. This section is not intended to provide 
a comprehensive data analysis plan because 
there are several good textbooks that can provide 
guidance on approaches to qualitative data anal-
ysis.29–39 This section, instead, provides practical 
advice for conducting qualitative analyses. 
Key strategies for analyzing qualitative data 
include designing an analysis plan, becoming 
familiar with the data, categorizing the data, 
identifying patterns and connections within the 
data, and interpreting the data. There are several 
qualitative data analysis software programs that 
can aid in the analysis, including ATLAS.ti, NVivo, 
MAXQDA, Dedoose, and QDA Miner. All of these 
programs have strengths and weaknesses and 
choosing one will depend on the types on anal-
yses that will be performed. Each program has 
user-friendly resources to aid in conducting the 
analyses. 
Recommended strategies for conducting qualita-
tive data analyses:
• Design an analysis plan: A data analysis plan 
helps in structuring the analyses and ensuring 
all team members are informed of how the 
data will be analyzed. Design an analysis plan 
that reflects the aims of the data collection 
and the questions that program planners are 
trying to answer. Program planners might want 
to focus the analyses by topic, an event, or 
learnings from a group. 
• Outline transcription expectations: Data 
collected are usually transcribed into written 
text for analyses. Good quality transcription is 
fundamental to the data analysis process. The 
level and detail of transcription will vary and 
it is important to outline these expectations 
from the beginning. For example, decisions 
must be made regarding whether verbal and 
non-verbal information should be included. 
The decisions on transcription are dependent 
on the research aims. 
• Start the analysis as data is being collected: 
Analyses of qualitative data is an iterative 
process that starts during data collection and 
continues beyond data collection. As data is 
collected, program planners should listen to 
recordings and read transcripts on an ongoing 
basis in order to understand the quality of 
the data and to refine questions and explore 
emergent topics not previously considered in 
subsequent interviews or group discussions. 
Additionally, field notes should include a 
summary of the interview and these notes 
should be reviewed continually. 
• Coding and analysis: The next step in the 
analysis process usually involves data 
condensation or reduction process, through 
coding the data and drafting analytic memos, 
pertaining to the major themes emergent from 
the data and/or the themes of interest. It is 
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consist of close-ended questions. Traditionally, 
surveys have been used to generalize to the 
larger population. Surveys allow for large sam-
ples and standardized responses. Technology, 
when used, increases the ease of survey admin-
istration, allowing for quick collection of data 
and minimization of errors. Care is needed when 
designing surveys and analyzing their results, to 
ensure that the right questions are being asked, 
the right people are taking the survey, the ap-
propriate number of people of surveyed, and the 
results are valid. 
Several courses and textbooks can provide 
specific quidance on quantitative survey data 
analysis.42
Conjoint Analysis
Conjoint analysis, a development of market 
research, is a set of techniques used to study 
customers’ decision-making processes and 
determining tradeoffs.43-45 Conjoint analysis has 
the ability to answer various “what if” questions 
based on the results of an analysis of data 
collected on hypothetical and real choice alter-
natives. The method uses a survey that outlines 
the attributes and characteristics about a prod-
uct, which is administered to a sample of the 
population that the product will eventually target. 
Various analytic models, with the assistance of 
easy-to-use software, are conducted using the 
collected survey data to predict how users will 
choose products and services. 
Conjoint analysis can be used to elicit poten-
tial PrEP users’ views of the drug, including the 
importance and trade-offs of different char-
acteristics (e.g., frequency of use, HIV testing 
requirement) of the drug. Additional factors that 
can be assessed in conjoint analyses include 
identifying priority healthcare settings for pro-
viding PrEP as well as the relative importance 
of different contextual influences (e.g., partner 
preferences, stigma) on product views. 
important at this stage of the analysis process 
to develop a codebook, particularly if multiple 
research team members will be involved in 
reviewing and coding the data. The codebook 
aids in the systematic coding of text. For each 
code (theme), the codebook outlines the 
name of the code, its definition, guidelines 
for when to use and not to use the code, 
and examples. Due to the iterative nature of 
qualitative data analysis, the codebook can be 
refined several times during the analysis. 
• Data display: Data display (through matrices, 
flow charts, etc.) can assist in assembling 
data across themes and respondents to better 
elucidate the relationships among themes, 
groups of respondents, and categories of 
data. This critical step allows for comparison 
and contrasting of findings across and within 
respondents. 
• Assess reliability and validity: It is important 
to assess the validity and reliability of findings 
to ensure that the findings reflect the reality 
of the participants’ lives and that the findings 
can be consistent, respectively. Closely 
rereading transcriptions, triangulating data 
from various sources, and obtaining feedback 
from participants are common methods for 
assessing reliability and validity.
• Interpretation of findings: One of the most 
important steps in qualitative analysis 
involves the interpretation of findings, 
drawing conclusions, and verification of the 
data interpretation. In this final stage, it is 
important to contextualize the findings with 
existing literature, connect to theory, and 
discuss alternate explanations/interpretations 
of the data. 
SURVEYS
Surveys are a method of gathering information 
from a defined group of people to get a broader 
understanding of the subject. Surveys mostly 
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Research utilization is the process by which 
research findings are synthesized and dissemi-
nated to make an impact on or change in existing 
practices. Translating findings into action at the 
national, sub-national, and service delivery levels 
requires two-way information exchange between 
the people who can apply research findings (i.e., 
stakeholders) and researchers or program plan-
ners.
Research utilization is a critical component of 
the research process and a necessary step for 
developing PrEP introduction strategies for AGYW. 
In Box 6 (page 34), we highlight seven practices 
that increase the likelihood that key stakehold-
ers will promote and utilize study findings and 
recommendations to make programmatic and 
policy decisions. These practices are drawn from 
a guidance document developed by Project SOAR 
(Supporting Operational AIDS Research), an 
operations research project led by the Population 
Council. This document can guide the planning 
and implementation for effective research utili-
zation. We recommend program planners and 
researchers access the complete resource, “Proj-
ect SOAR’s research utilization process: guidance 
document and toolkit,” at http://www.popcouncil.
org/uploads/pdfs/2016HIV_ProjectSOAR_ResUt-
ilization.pdf.
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BOX 6  
Research utilization practices
Practice 1: Identify key stakeholders as early as possible to understand their priority information 
needs and establish the audience(s) for the findings. This will enhance the study’s relevance 
among those implementing HIV programs and services and development partners investing in 
the programs.
Practice 2: Engage stakeholders during study design to ensure that the methods, intervention (if 
there is one), and data collection processes reflect and respond to the priorities and needs of the 
HIV program and services.
Practice 3: Establish a study-specific advisory panel that assigns roles and responsibilities to 
key stakeholders. This will help ensure that stakeholders remain engaged throughout the study 
process and will want to champion the use of findings once they become available.
Practice 4: Engage stakeholders during data collection to reinforce their involvement and 
deepen their understanding of the research process and what the study is investigating. This 
can also help improve fidelity to the intervention under study, if there is one. Engaging key 
stakeholders during data collection may motivate them to later use findings and disseminate 
them among a wider audience.
Practice 5: Work together with stakeholders to interpret findings and develop recommendations. 
Engaging stakeholders permits them to review preliminary analyses and offer insight into the 
local program context, which informs specific and realistic recommendations. 
Practice 6: Produce the study report and hold the dissemination meeting, during which 
stakeholders finalize a plan to use findings and recommendations. 
Practice 7: Coordinate the implementation of the plan to use findings and recommendations. 
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